Table 2.
Difference between high and low BNF factors.
| N = 272 |
High |
Low |
p value | |
|---|---|---|---|---|
| N = 19 | N = 253 | |||
| Age, N (%) | 18 | 0 | 3 (1.2) | 0.415 |
| 19–39 | 8 (42.1) | 143 (56.5) | ||
| 40–69 | 11 (57.9) | 103 (40.7) | ||
| >=70 | 0 | 4 (1.6) | ||
| Gender, N (%) | Male | 11 (57.9) | 101 (39.9) | 0.125 |
| Female | 8 (42.1) | 152 (60.1) | ||
| Antipsychotic therapeutic class, N (%) | Atypical | 11 (57.9) | 198 (78.3) | 0.042* |
| Typical | 8 (42.1) | 55 (21.7) | ||
| Number of medication, mean (SD), count | 4.26 (2.18) | 2.33 (1.62) | <0.001* | |
| Number of admission days, median (IQR), days | 73.00 (36.00–––110.00) | 30.00 (23.00–––36.00) | 0.275 | |
| Aripiprazole | 10 (52.6) | 135 (53.4) | 0.951 | |
| Haloperidol | 11 (57.9) | 77 (30.4) | 0.014* | |
| Quetiapine | 9 (47.4) | 56 (22.1) | 0.022* | |
| Risperidone | 3 (15.8) | 61 (24.1) | 0.578 | |
| Olanzapine | 10 (52.6) | 48 (19.0) | 0.002* | |
| Amisulpride | 1 (5.3) | 21 (8.3) | 1.000 | |
| Clozapine | 2 (10.5) | 20 (7.9) | 0.658 | |
| Chloropromazine | 1 (5.3) | 8 (3.2) | 0.484 | |
| Paliperidone | 3 (15.8) | 5 (2.0) | 0.013* | |
| Zuclopenthixol | 2 (10.5) | 4 (1.6) | 0.059 | |
*significant at p-value < 0.05; bold indicate significantly higher percent or value.